Shalabh K. Gupta
CEO at Unicycive Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Unicycive Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Unicycive Therapeutics Inc. June 19, 202697.9%
-
Unicycive Therapeutics Inc. June 9, 202596.1%
-
Unicycive Therapeutics Inc. June 20, 202499.6%
-
Unicycive Therapeutics Inc. June 26, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 11, 2023 | Unicycive Therapeutics Inc. | Option exercise | +104,612 | — | — |
Questions about Shalabh K. Gupta
What boards is Shalabh K. Gupta on?
Shalabh K. Gupta sits on the board of Unicycive Therapeutics Inc.
What company is Shalabh K. Gupta the CEO of?
Shalabh K. Gupta is CEO of Unicycive Therapeutics Inc.
How long has Shalabh K. Gupta served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.